Hong Mei Xie from Ridgewood, NY, age 54

Medicine Doctors

Hong Xie

view source

Specialties:

Diagnostic Radiology, Radiology

Work:

Radiology Associates Of The Fox Valley SC
430 E Division St, Fond du Lac, WI 54935
(920)8867525 (phone), (920)7227454 (fax)

Radiology Associates Of Fox Valley
333 N Commercial St STE 100, Neenah, WI 54956
(920)9671000 (phone), (920)7227454 (fax)

Education:

Medical School
Beijing Med Univ, Beijing City, Beijing, China
Graduated: 1989

Languages:

English

Description:

Dr. Xie graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1989. She works in Neenah, WI and 1 other location and specializes in Diagnostic Radiology and Radiology. Dr. Xie is affiliated with Mercy Medical Center, Saint Elizabeth Hospital, St Agnes Hospital and Theda Care Regional Medical Center.

Resumes

Hoppitality

view source

Location:

Philadelphia, PA

Work:

Omg Live
Hoppitality

Education:

Penn State University 2012 - 2016

Senior Marketing Manager

view source

Location:

Philadelphia, PA

Work:

Amgen
Senior Marketing Manager

Education:

University of Pennsylvania

Executive Director

view source

Location:

Lansdale, PA

Industry:

Pharmaceuticals

Work:

Johnson & Johnson since May 2007
Director
Centocor since May 2007
Associate Director
GSK 2002 - 2004
Senior Clinical Scientist
Merck & Co., Inc. 2000 - 2002
MPC

Education:

Lehigh University - College of Business and Economics 2003 - 2008
MBA, Business Administration Peking University 1990 - 1993
MS, Molecular Biology and Biochemistry Peking University 1985 - 1990
M.D., Medicine

Skills:

Oncology
Hematology
Immunology
Clinical Development
Ind Or Nda Ffilings
Molecular Biology and Biochemistry
Cell
Translational Research
Biopharmaceuticals
Biotechnology
Infectious Diseases
Drug Discovery
Clinical Trials
Drug Development
Cro
Cancer
Pharmaceutical Industry
Gcp
Ctms
Medical Writing
Clinical Research

Hong Xie

view source

Hong Xie

view source

Hong Xie

view source

Hong Xie

view source

Professional

view source

Location:

United States

Us Patents

System For Statistically Multiplexing Real-Time And Non-Real-Time Voice And Data Traffic In A Wireless System
view source
US Patent:

6963544, Nov 8, 2005
Filed:

Aug 31, 2000
Appl. No.:

09/651717
Inventors:

Krishna Balachandran - Middletown NJ, US
Cristian Demetrescu - Twickenham, GB
Richard Paul Ejzak - Wheaton IL, US
Sanjiv Nanda - Clarksburg NJ, US
Hong Xie - Downers Grove IL, US
Assignee:

Lucent Technologies Inc. - Murray Hill NJ
International Classification:

H04J001/08
US Classification:

370281, 370295, 370330, 370343, 370436, 370478, 370480, 370498
Abstract:

A system for providing statistical multiplexing of speech, other real-time data services and non-real-time data services for point to point and point to multipoint communications. The system has fast access and assignment procedures that allow the multiplexing of real-time, delay-critical data services with non-real-time data services. Continuity of periodic control channels across speech talkspurt and silence periods for conversational voice is maintained to carry signal measurement reports, channel quality feedback, and “comfort” noise information between different parts of the system.

Methods Of Treating Renal Cancer With An Anti- Psma/Cd3 Antibody
view source
US Patent:

20210079115, Mar 18, 2021
Filed:

Apr 17, 2020
Appl. No.:

16/852371
Inventors:

- Horsham PA, US
Shoba Shetty - Yardley PA, US
Hong Xie - Dresher PA, US
International Classification:

C07K 16/30
C07K 16/28
A61P 35/00
Abstract:

Bispecific monoclonal antibodies and methods for treating cancer are set forth herein.

Methods Of Treating Prostate Cancer With An Anti- Psma/Cd3 Antibody
view source
US Patent:

20210040209, Feb 11, 2021
Filed:

Apr 17, 2020
Appl. No.:

16/852353
Inventors:

- Horsham PA, US
Shoba Shetty - Yardley PA, US
Hong Xie - Dresher PA, US
International Classification:

C07K 16/28
A61P 35/04
C07K 16/30
A61K 9/00
Abstract:

Bispecific monoclonal antibodies and methods for treating cancer are set forth herein.

Methods Of Treating Cancers With Antagonistic Anti-Pd-1 Antibodies
view source
US Patent:

20190225689, Jul 25, 2019
Filed:

Jan 18, 2019
Appl. No.:

16/252295
Inventors:

- Horsham PA, US
Kyounghwa BAE - Spring House PA, US
James G. GREGER - Wayne PA, US
Christine Lourdes MAYER - Dallas TX, US
Hong XIE - Dresher PA, US
International Classification:

C07K 16/28
A61P 35/00
Abstract:

The present invention relates to methods of treating cancers with antagonistic anti-PD-1 antibodies, formulations of the antagonistic anti-PD-1 antibodies and drug products of the anti-PD-1 antibodies.